Similarly, many tumor immune markers, such as prostate specific antigen (PSA), human epidermal growth factor receptor 2 (HER2) and endothelial growth factor receptor (EGFR), can also be used as antibodies for the specific recognition of CTCs [30, 31]. Here, KLK3 is linked to neoplasm.